Germans to be Denied Benlysta Coverage

Germany joins the UK in rejecting healthcare coverage for Benlysta, a new drug for lupus from GlaxoSmithKline and Human Genome Sciences.

Please visit to sign a petition calling for NICE to reconsider its position. The petition may help influence German authorities if NICE reconsiders its recommendation.

Full Story